The 2026 Global Artificial Intelligence Technology Conference (GAITC 2026), hosted by the Chinese Association for Artificial Intelligence, concluded successfully in Hangzhou on May 24, 2026. Centered on the theme of “Interdiscipline, Integration, Coexistence and Win-Win Cooperation”, the event brought together global elites, as well as representatives from governments, enterprises, universities and research institutions in intelligent technology. Integrated with conferences and exhibitions, the summit created an immersive platform for in-depth industry communication.
Focusing on computational imaging and artificial intelligence technologies, AINNOVI devotes itself to the R&D of domestically manufactured high-end microscopic medical equipment and smart healthcare. The company has realized the industrial upgrade of surgical procedures from 3D visualization to 3D intelligent intervention. At GAITC 2026, AINNOVI presented its intelligent microscopic medical solutions, discussing the future of AI-powered microsurgery with peers and earning widespread attention and favorable feedback.
AINNOVI has built a three-tier technical framework: multi-modal microscopic data platform, foundational AI model platform for microscopy, and application-oriented intelligent model platform. This complete smart microsurgery solution has been deployed in a wide range of surgical scenarios. By incorporating multi-modal data including 3D microscopic images, the system supports real-time dynamic risk warning and intraoperative intelligent 3D navigation. It effectively improves surgical accuracy and operational safety, delivering solid AI assistance for precision minimally invasive operations.
Government officials and academicians visited the booth. After learning about the core technologies and clinical outcomes, they spoke highly of the company’s innovative research achievements.
Shao Hang, Founder of AINNOVI, stated that the enterprise has launched an industry-leading 3D exoscopic surgical microscopy system. Relying on intraoperative 3D image data, the system realizes proprietary intelligent 3D navigation and real-time early warning functions. For years, AINNOVI has cooperated with key research platforms including Zhejiang Key Laboratory of Precision Ophthalmology. Supported by massive real-world clinical surgical data, the company takes multi-modal data fusion as the foundation and artificial intelligence as the core driving force to develop a full-stack smart healthcare system for clinical intelligent upgrading.
During the two-day exhibition, AINNOVI held extensive exchanges with global medical institutions, research institutes and industrial chain partners. Hot topics covered innovative integration of surgical microscopes, construction of smart operating room ecosystems, and independent R&D of high-end domestic medical devices. Many professionals tested the domestically developed exoscope with ultra-long working distance and the AI 3D surgical navigation platform, fully recognizing AINNOVI’s technical strength and clinical value.
Although GAITC 2026 has come to an end, AINNOVI’s technological exploration will continue unceasingly. The company will keep upgrading its product lineup with smarter, more precise and more reliable solutions to boost high-quality precision surgery. AINNOVI will continuously fuel the arrival of a new era of AI-driven microscopic smart healthcare.